PERSPECTIVE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 732.58 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-16
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-12-31 was 150.00K shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was 431.25K shares, a 331.25% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-06-30 was 673.89K shares, a 798.82% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 732.58K shares, a 88.83% increase from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 387.95K shares, a 69.09% decline from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.26M shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 488.68K shares, a 85.72% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 732.58K shares 10-K · filed 2026-03-16 | ||||
| 2024-12-31 | 387.95K shares 10-K/A · filed 2025-03-28 | ||||
| 2023-12-31 | 150.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 581.25K shares derived: sum of 2 quarters · filed 2024-03-28 | 1.26M shares derived: sum of 3 quarters · filed 2024-03-28 | 1.26M shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 431.25K shares 10-Q · filed 2023-11-14 | 1.11M shares derived: sum of 2 quarters · filed 2023-11-14 | 1.11M shares 10-Q · filed 2023-11-14 | 1.11M shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | 673.89K shares 10-Q · filed 2023-08-11 | 673.89K shares 10-Q · filed 2023-08-11 | 673.89K shares derived: sum of 3 quarters · filed 2024-03-28 | 773.89K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 100.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 174.97K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | 0.00 shares derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | 100.00K shares 10-K · filed 2024-03-28 | 174.97K shares derived: sum of 3 quarters · filed 2024-03-28 | 588.67K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-09-30 | 100.00K shares 10-Q · filed 2023-11-14 | 174.97K shares derived: sum of 2 quarters · filed 2023-11-14 | 432.45K shares 10-Q · filed 2023-11-14 | 612.40K shares derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 74.97K shares 10-Q · filed 2023-08-11 | 332.45K shares 10-Q · filed 2023-08-11 | 512.40K shares derived: sum of 3 quarters · filed 2023-08-11 | 488.68K shares 10-K · filed 2024-03-28 | |
| 2022-03-31 | 413.70K shares 10-Q · filed 2023-05-15 | 257.48K shares 10-Q · filed 2022-05-13 | 437.43K shares derived: sum of 2 quarters · filed 2023-05-15 | 413.70K shares 10-Q · filed 2022-05-13 | 595.55K shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 23.73K shares 10-Q · filed 2022-02-09 | 156.22K shares 10-Q · filed 2022-02-09 | 181.85K shares derived: sum of 3 quarters · filed 2023-05-01 | 416.23K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-09-30 | 132.50K shares 10-Q · filed 2022-11-14 | 158.13K shares derived: sum of 2 quarters · filed 2023-05-01 | 392.50K shares derived: sum of 3 quarters · filed 2023-05-01 | 393.13K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-06-30 | 25.63K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | 260.00K shares derived: sum of 2 quarters · filed 2023-05-01 | 260.63K shares derived: sum of 3 quarters · filed 2023-05-01 | 263.13K shares 10-KT · filed 2023-05-01 | |
| 2021-03-31 | 234.38K shares 10-Q · filed 2022-05-13 | 235.00K shares derived: sum of 2 quarters · filed 2022-05-13 | 237.50K shares 10-Q · filed 2022-05-13 | 233.75K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-12-31 | 625.00 shares 10-Q · filed 2022-02-09 | 3.13K shares 10-Q · filed 2022-02-09 | -625.00 shares derived: sum of 3 quarters · filed 2023-05-01 | -625.00 shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-09-30 | 2.50K shares 10-Q · filed 2021-11-10 | -1.25K shares derived: sum of 2 quarters · filed 2023-05-01 | -1.25K shares derived: sum of 3 quarters · filed 2023-05-01 | -1.25K shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-06-30 | -3.75K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | -3.75K shares derived: sum of 2 quarters · filed 2023-05-01 | -3.75K shares derived: sum of 3 quarters · filed 2023-05-01 | 22.50K shares 10-KT · filed 2023-05-01 | |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2021-05-14 | 26.25K shares 10-Q · filed 2021-05-14 | 23.63K shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-12-31 | 0.00 shares 10-Q · filed 2021-02-09 | 26.25K shares 10-Q · filed 2021-02-09 | 23.63K shares derived: sum of 3 quarters · filed 2021-09-27 | 23.63K shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-09-30 | 26.25K shares 10-Q · filed 2020-11-13 | 23.63K shares derived: sum of 2 quarters · filed 2021-09-27 | 23.63K shares derived: sum of 3 quarters · filed 2021-09-27 | 55.63K shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-06-30 | -2.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | -2.63K shares derived: sum of 2 quarters · filed 2021-09-27 | 29.38K shares derived: sum of 3 quarters · filed 2021-09-27 | 68.13K shares 10-K · filed 2021-09-27 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-13 | 32.00K shares derived: sum of 2 quarters · filed 2020-05-13 | 70.75K shares 10-Q · filed 2020-05-13 | 518.25K shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-12-31 | 32.00K shares 10-Q · filed 2020-02-12 | 70.75K shares 10-Q · filed 2020-02-12 | 518.25K shares derived: sum of 3 quarters · filed 2020-09-25 | 555.75K shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-09-30 | 38.75K shares 10-Q · filed 2019-11-13 | 486.25K shares derived: sum of 2 quarters · filed 2020-09-25 | 523.75K shares derived: sum of 3 quarters · filed 2020-09-25 | 540.63K shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-06-30 | 447.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | 485.00K shares derived: sum of 2 quarters · filed 2020-09-25 | 501.88K shares derived: sum of 3 quarters · filed 2020-09-25 | 561.54K shares 10-K · filed 2020-09-25 | |
| 2018-03-31 | 37.50K shares 10-Q · filed 2019-05-10 | 54.38K shares derived: sum of 2 quarters · filed 2019-05-10 | 114.04K shares 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | 16.88K shares 10-Q · filed 2019-02-13 | 76.54K shares 10-Q · filed 2019-02-13 | |||
| 2017-09-30 | 59.67K shares 10-Q · filed 2018-11-09 | ||||
| 2017-03-31 | 96.43K shares 10-Q · filed 2018-05-04 | 144.10K shares derived: sum of 2 quarters · filed 2018-05-04 | 179.44K shares 10-Q · filed 2018-05-04 | ||
| 2016-12-31 | 47.67K shares 10-Q · filed 2018-02-09 | 83.00K shares 10-Q · filed 2018-02-09 | |||
| 2016-09-30 | 35.34K shares 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | 162.87K shares 10-K · filed 2018-09-26 | ||||
| 2014-12-31 | 84.24K shares 10-Q · filed 2015-02-17 | ||||
| 2012-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | 37.53K shares 10-Q · filed 2013-02-14 | |||
| 2012-09-30 | 37.53K shares 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |